Beryl Drugs is not listed on NSE
Only SellersOnly Sellers in Beryl Drugs on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 48.00 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 41.90 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 36.00 on BSE
52 Week HighBeryl Drugs has hit a 52wk high of Rs 32.50 on BSE
AnnouncementsBeryl Drugs; Outcome of adjourned board meeting
AnnouncementsBeryl Drugs: Board meeting on Feb 12, 2014
AnnouncementsBeryl Drugs board meeting on Jan 25, 2014
52 Week LowBeryl Drugs has hit 52wk low of Rs 15.05 on BSE
52 Week LowBeryl Drugs has hit 52wk low of Rs 16.00 on BSE
52 Week LowBeryl Drugs has hit 52wk low of Rs 17.05 on BSE
AnnouncementsBeryl Drugs board meeting on April 26, 2013
No recommendations so far.What's your call on Beryl Drugs today? Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2556.00||0.66||2939.80||1904.15||43,479.83|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Beryl Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 16.29 crore.The company has reported a standalone sales of Rs 3.74 crore and a Net Profit of Rs 0.15 crore for the quarter ended Dec 2013.
The company management includes Sanjay Sethi - Chairman & Managing Director, Sudhir Sethi - Whole Time Director, Sunil Jain - Director, Hemant Jain - Director, Avinash Sharma - Director, Bagachand Jain - Director.
It is listed on the BSE with a BSE Code of 524606.
Its Registered office is at 133, Kanchan Bag , Indore,Madhya Pradesh - 452001.
Their Registrars are Adroit Corporate Service (P) Ltd.